Edition:
United States

Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

112.08USD
2 Dec 2016
Change (% chg)

$0.33 (+0.30%)
Prev Close
$111.75
Open
$112.20
Day's High
$113.10
Day's Low
$111.84
Volume
354,630
Avg. Vol
372,919
52-wk High
$123.50
52-wk Low
$86.70

Summary

Name Age Since Current Position

Kevin Lobo

50 2016 Chairman of the Board, Chief Executive Officer

Glenn Boehnlein

2016 Chief Financial Officer, Vice President

Lonny Carpenter

54 2009 Group President - Global Quality and Operations

David Floyd

55 2012 Group President - Orthopaedics

Timothy Scannell

51 2013 Group President - MedSurg and Neurotechnology

William Berry

50 2014 Principal Accounting Officer, Vice President, Corporate Controller

Bijoy Sagar

47 2014 Chief Information Officer, Vice President

M. Fink

46 2016 Vice President - Global Human Resources

Katherine Owen

45 2007 Vice President - Strategy and Investor Relations

Yin Becker

52 2016 Vice President - Communication and Public Affairs

Michael Hutchinson

45 2014 General Counsel

Howard Cox

73 1974 Independent Director

Srikant Datar

62 2009 Independent Director

Roch Doliveux

59 2010 Independent Director

Louise Francesconi

62 2006 Independent Director

Allan Golston

49 2011 Independent Director

Andrew Silvernail

45 2013 Independent Director

Ronda Stryker

61 1984 Independent Director

Biographies

Name Description

Kevin Lobo

Mr. Kevin A. Lobo has been appointed as Chairman of the Board, Chief Executive Officer of the company. Mr. Lobo was named Chairman of the Board in July 2014 and has served as President and Chief Executive Officer of the Company since 2012. He joined the Company as a Group President in April 2011. Prior thereto, he held several senior leadership roles over eight years with Johnson & Johnson, including serving as president of Ethicon Endo-Surgery and president of J&J’s Medical Products business in Canada. Mr. Lobo is also a director of Parker-Hannifin Corporation, a manufacturer of motion and control technologies and systems. Mr. Lobo’s more than 25 years of global business and leadership experience across multiple industries, including healthcare, enables him to provide valuable insight to the Board regarding the Company’s operations and the strategic planning initiatives necessary to meet the demands of the changing environment. As the sole member of management on our Board, he provides management’s business perspectives and the necessary link to the day-to-day operations.

Glenn Boehnlein

Mr. Glenn Boehnlein is Chief Financial Officer, Vice President of Stryker Corporation. Glenn joined Stryker in 2003 as the Vice President of Finance and IT for Stryker’s Endoscopy division and has taken on roles of increasing responsibility, including his current role as Group CFO of MSNT, which he assumed in 2011. He has a strong and established track record and will continue to uphold the financial standards and practices that enable Stryker’s growth. Glenn’s career began with achieving a CPA degree and rising to Partner at Arthur Andersen, where he worked with large private and public companies, including private offerings and M&A transaction consulting. He then spent three years with Success TV as the company’s CFO prior to joining Stryker. Glenn received his Bachelors and Masters in Accounting from Mississippi State University.

Lonny Carpenter

Mr. Lonny J. Carpenter is Group President - Global Quality and Operations of the company. He was the Group President, Instruments and Medical since November 2008. He had previously been President, Stryker Medical since May 2008 and Vice President and General Manager, Stryker Medical since 2006. After joining the Company in 1989, Mr. Carpenter held various roles of increasing responsibility at Stryker Instruments before being promoted to Vice President, Global Operations, Stryker Instruments in 2004.

David Floyd

Mr. David K. Floyd is Group President - Orthopaedics of the company. Mr. Floyd joins Stryker after 25 years in the medical technology and orthopaedics industry where he held a number of senior level leadership roles at DePuy, a division of Johnson and Johnson, Abbott Spine, AxioMed Spine, Centerpulse Orthopaedics and most recently as Chief Executive Officer for OrthoWorx.

Timothy Scannell

Mr. Timothy J. Scannell is Group President - MedSurg and Neurotechnology of the company. He was Group President, Spine and Endoscopy since November 2008. He had previously been President, Stryker Spine since 2005 and Vice President and General Manager, Stryker Spine since 2003. After joining the Company in 1990, Mr. Scannell is leadership roles at Stryker Endoscopy before being promoted to Vice President and General Manager, Stryker Biotech in 2001.

William Berry

Mr. William E. Berry, Jr., serves as Principal Accounting Officer, Vice President, Corporate Controller of the company.

Bijoy Sagar

Mr. Bijoy S.N. Sagar serves as Chief Information Officer, Vice President of the company.

M. Fink

Ms. M. Kathryn Fink is a Vice President - Global Human Resources of the company.

Katherine Owen

Ms. Katherine Ann Owen is Vice President - Strategy and Investor Relations of the company. Prior to joining the Company, she served as a medical technology analyst at Merrill Lynch. Prior to that she held a similar position at Cowen & Co./SG Cowen and had been a corporate lending analyst at State Street Bank.

Yin Becker

Yin C. Becker is a Vice President - Communication and Public Affairs of the company.

Michael Hutchinson

Mr. Michael D. Hutchinson serve as General Counsel of the company.

Howard Cox

Mr. Howard E. Cox, Jr., is Independent Director of Stryker Corp., since 1974. He is Special Limited Partner of Greylock and its affiliated venture capital partnerships since 1971. He is also a Director Secretary of Defense Business Board, a member of the Harvard Medical School Board of Fellows and a member of the Investment Committees of the Dana Farber Cancer Institute, Partners Healthcare System, Inc. and the Boston Museum of Fine Arts. Mr. Cox has a broad and deep level of experience as a board member, having served on over 30 boards of directors, including many that were public companies and a number of which were in the healthcare industry. His extensive experience in the venture capital business has given him valuable insight in assessing overall business risks, particularly related to acquisitions. Having served on the Stryker Board for over 40 years, he brings a valuable historical context to our Board

Srikant Datar

Dr. Srikant M. Datar, Ph.D., is Independent Director of Stryker Corp., since July 29, 2009. He serves at Arthur Lowes Dickinson Professor at the Graduate School of Business Administration of Harvard University since 1996 and Senior Associate Dean from 2001 to 2010. From 1989 to 1996, he was Edmund W. Littlefield Professor at the Graduate School of Business, Stanford University. He is also a director of Novartis AG, a multinational pharmaceutical and consumer health products company, ICF International, Inc., a management, technology and policy consulting firm, and T-Mobile US, Inc., a provider of wireless voice, messaging and data services. Dr. Datar has an extensive background in accounting and finance and a variety of other business areas, including organization design and performance measurement. His strong accounting and finance background and his experience as chair of the Audit Committee at Novartis AG and T-Mobile US, Inc. allow him to make significant contributions on our Audit Committee. His service on the boards of global companies involved in pharmaceuticals and high tech gives him great insights on assessing Stryker’s technology and strategies to expand our business globally.

Roch Doliveux

Dr. Roch Doliveux, DVM, is Independent Director of Stryker Corp., since June 21, 2010. He served as Former Chief Executive Officer and Chairman of the Executive Committee of UCB S.A., a global biopharmaceutical company, from 2005 through 2014. Prior thereto, he was Chief Executive Officer of Pierre Fabre Pharmaceuticals and President of Schering-Plough International, a subsidiary of Schering-Plough Corporation. He is Chairman of the GLG Healthcare Institute and chairs the Board of the Vlerick Business School, a top-100 business school in the world based in Belgium. Dr. Doliveux has extensive experience in life science and healthcare companies, including product management, global marketing, research and development, and strategic and organizational change management. His exposure to business in many geographies and cultures is very valuable as Stryker seeks to expand its global presence.

Louise Francesconi

Ms. Louise L. Francesconi is Independent Director of Stryker Corp., since July 26, 2006. She is Former Vice President of Raytheon Company and former President of Raytheon Missile Systems, which she led from 1996 to July 2008. She is Chairman of the Tucson Medical Center Healthcare Board of Trustees and a director of UNS Energy Corporation, a utility that delivers natural gas and electric service. Ms. Francesconi’s extensive experience in various leadership roles in operations and finance functions at Raytheon and other major businesses for over 30 years enable her to bring a wealth of insight into the complex operational, financial and governance issues facing the Company. Her role as Chairman of the Tucson Medical Center Board also has provided useful insights from the perspective of a healthcare provider.

Allan Golston

Mr. Allan C. Golston is Independent Director of Stryker Corp., since January 1, 2011. He served as President, United States Program for the Bill & Melinda Gates Foundation since 2006, and Chief Financial and Administrative Officer of the Bill & Melinda Gates Foundation from 2000 to 2006. Mr. Golston has extensive experience in auditing, finance and the healthcare industry. He is a Certified Public Accountant and has held positions as a finance executive with Swedish Health Services (Seattle, WA) and the University of Colorado Hospital. In his service to the Gates Foundation, he has contributed to the strategic formation and operation of successful initiatives to provide healthcare, education and other human needs, all of which give him understanding that will assist Stryker in our global efforts to meet the needs of patients and caregivers. Additionally, Mr. Golston’s expertise and experience in financial matters enable him to make valuable contributions to our Audit Committee.

Andrew Silvernail

Mr. Andrew K. Silvernail is Independent Director of the company. He is Chairman, President and Chief Executive Officer of IDEX Corporation, Chairman since 2012 and President and Chief Executive Officer since 2011, and Vice President, Group Executive from January 2009 to August 2011. Mr. Silvernail is also a trustee for the Manufacturers Alliance for Productivity and Innovation (MAPI). By virtue of service as Chairman, President and Chief Executive Officer of IDEX Corporation and his prior experience in executive leadership positions with IDEX and another large public company, Mr. Silvernail provides valuable business, leadership and management insights and useful perspectives to our Board discussions. His experience leading a large public company with global operations gives him a clear understanding of the issues facing a multinational business such as ours.

Ronda Stryker

Ms. Ronda E. Stryker is Independent Director of Stryker Corp., since 1984. She is also Vice Chair and a director of Greenleaf Trust, a Michigan chartered bank, Vice Chair of Spelman College, a trustee of Kalamazoo College and member of the Harvard Medical School Board of Fellows. Ms. Stryker brings a strong interest in advocating the benefits of diversity and various matters regarding social responsibility. As the Company’s largest individual shareholder and a member of the founding family, she brings a strong shareholder perspective, unlike that of any other member of our Board, making her a valuable component of a well-rounded Board.